Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE).
Roni Nitecki WilkeJose Alejandro Rauh-HainAlexander MelamedGiovanni ScambiaRene ParejaRobert L ColemanPedro T RamirezAnna FagottiPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
To demonstrate non-inferiority with a margin of 33% in the hazard ratio (HR=1.33), 549 patients will be randomized.